• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素治疗的糖尿病患者非严重低血糖治疗的最佳碳水化合物剂量:一项叙述性综述。

Optimal Carbohydrate Dose for Treatment of Nonsevere Hypoglycemia in Insulin-Treated Patients With Diabetes: A Narrative Review.

作者信息

Urbanová Jana, Frier Brian M, Taniwall Arian, Brožová Klára, Malinovská Jana, Chandel Aviral, Brož Jan

机构信息

Center for Research in Diabetes, Metabolism and Nutrition, Department of Internal Medicine Faculty, Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.

Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

Can J Diabetes. 2022 Oct;46(7):743-749.e4. doi: 10.1016/j.jcjd.2022.03.011. Epub 2022 Apr 6.

DOI:10.1016/j.jcjd.2022.03.011
PMID:35995674
Abstract

Nonsevere hypoglycemia in people with diabetes is usually treated with rapid-acting carbohydrate, of which glucose is the most suitable form. A quantity of 15 g is recommended and repeated after 15 min if hypoglycemia persists. This recommendation has not changed for several years despite the introduction of continuous glucose monitoring, newer and more flexible insulin regimens and improved insulin delivery. The present review has examined published studies that have explored how effectively defined amounts of carbohydrate treat nonsevere hypoglycemia in adults with insulin-treated diabetes. For most nonsevere episodes of hypoglycemia, the optimal treatment is 15 to 20 g of oral glucose. However, this dose may not be appropriate with many current insulins and insulin pump therapy, where doses of glucose may have to be individualized, based on body weight or type of insulin delivery system. Current guidelines on hypoglycemia treatment for newer glucose-lowering therapies may require re-evaluation.

摘要

糖尿病患者的非严重低血糖通常用速效碳水化合物治疗,其中葡萄糖是最合适的形式。建议用量为15克,若低血糖持续,15分钟后重复使用。尽管引入了持续葡萄糖监测、更新且更灵活的胰岛素治疗方案以及改进的胰岛素给药方式,但这一建议多年来一直未变。本综述研究了已发表的研究,这些研究探讨了规定量的碳水化合物治疗胰岛素治疗的成年糖尿病患者非严重低血糖的效果。对于大多数非严重低血糖发作,最佳治疗方法是口服15至20克葡萄糖。然而,对于许多当前的胰岛素和胰岛素泵治疗,该剂量可能不合适,在这些治疗中,葡萄糖剂量可能需要根据体重或胰岛素给药系统类型进行个体化调整。关于新型降糖疗法低血糖治疗的当前指南可能需要重新评估。

相似文献

1
Optimal Carbohydrate Dose for Treatment of Nonsevere Hypoglycemia in Insulin-Treated Patients With Diabetes: A Narrative Review.胰岛素治疗的糖尿病患者非严重低血糖治疗的最佳碳水化合物剂量:一项叙述性综述。
Can J Diabetes. 2022 Oct;46(7):743-749.e4. doi: 10.1016/j.jcjd.2022.03.011. Epub 2022 Apr 6.
2
Efficacy of Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes Using Oral Carbohydrates During Automated Insulin Delivery With and Without Glucagon.使用自动胰岛素输送和不使用胰高血糖素的情况下,口服碳水化合物治疗 1 型糖尿病非重度低血糖的疗效。
Can J Diabetes. 2023 Jul;47(5):445-450. doi: 10.1016/j.jcjd.2023.04.013. Epub 2023 Apr 22.
3
Treatment of Hypoglycemia in Adult Patients with Type 1 Diabetes: An Observational Study.成人 1 型糖尿病患者低血糖的治疗:一项观察性研究。
Can J Diabetes. 2016 Aug;40(4):318-23. doi: 10.1016/j.jcjd.2016.05.008. Epub 2016 Jun 30.
4
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.用于 1 型和 2 型成年糖尿病患者群体的持续皮下胰岛素输注(CSII)泵:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.
5
The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.持续皮下胰岛素泵联合持续血糖监测在门诊1型糖尿病青少年患者中的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-10. doi: 10.11124/jbisrir-2012-170.
6
Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?胰岛素泵治疗的 1 型糖尿病患者轻中度低血糖的治疗:现行推荐有效吗?
Acta Diabetol. 2018 Mar;55(3):227-231. doi: 10.1007/s00592-017-1085-8. Epub 2017 Dec 9.
7
Predictors of nonsevere and severe hypoglycemia during glucose-lowering treatment with insulin glargine or standard drugs in the ORIGIN trial.ORIGIN 试验中甘精胰岛素或标准药物降糖治疗期间非严重和严重低血糖的预测因素。
Diabetes Care. 2015 Jan;38(1):22-8. doi: 10.2337/dc14-1329. Epub 2014 Oct 28.
8
EMS Diabetic Protocols For Treat and Release急诊医疗服务糖尿病治疗与出院协议
9
Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.小剂量胰高血糖素治疗 1 型糖尿病成人非重度低血糖的疗效和安全性。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2994-3001. doi: 10.1210/jc.2017-00591.
10
EADSG Guidelines: Insulin Therapy in Diabetes.欧洲糖尿病研究学会指南:糖尿病的胰岛素治疗
Diabetes Ther. 2018 Apr;9(2):449-492. doi: 10.1007/s13300-018-0384-6. Epub 2018 Mar 5.

引用本文的文献

1
Non-severe hypoglycemia in type 1 diabetes: a randomized crossover trial comparing two quantities of oral carbohydrates at different insulin-induced hypoglycemia ranges.1 型糖尿病患者的非严重低血糖:两种不同胰岛素诱导低血糖范围内口服碳水化合物量的随机交叉试验。
Front Endocrinol (Lausanne). 2023 Jun 2;14:1186680. doi: 10.3389/fendo.2023.1186680. eCollection 2023.